<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Goodwin AC</submitter><funding>NIDDK NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>15354-9</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3174648</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>108(37)</volume><pubmed_abstract>It is estimated that the etiology of 20-30% of epithelial cancers is directly associated with inflammation, although the direct molecular events linking inflammation and carcinogenesis are poorly defined. In the context of gastrointestinal disease, the bacterium enterotoxigenic Bacteroides fragilis (ETBF) is a significant source of chronic inflammation and has been implicated as a risk factor for colorectal cancer. Spermine oxidase (SMO) is a polyamine catabolic enzyme that is highly inducible by inflammatory stimuli resulting in increased reactive oxygen species (ROS) and DNA damage. We now demonstrate that purified B. fragilis toxin (BFT) up-regulates SMO in HT29/c1 and T84 colonic epithelial cells, resulting in SMO-dependent generation of ROS and induction of ?-H2A.x, a marker of DNA damage. Further, ETBF-induced colitis in C57BL/6 mice is associated with increased SMO expression and treatment of mice with an inhibitor of polyamine catabolism, N(1),N(4)-bis(2,3-butandienyl)-1,4-butanediamine (MDL 72527), significantly reduces ETBF-induced chronic inflammation and proliferation. Most importantly, in the multiple intestinal neoplasia (Min) mouse model, treatment with MDL 72527 reduces ETBF-induced colon tumorigenesis by 69% (P &lt; 0.001). The results of these studies indicate that SMO is a source of bacteria-induced ROS directly associated with tumorigenesis and could serve as a unique target for chemoprevention.</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis.</pubmed_title><pmcid>PMC3174648</pmcid><funding_grant_id>R01 CA098454</funding_grant_id><funding_grant_id>R01 DK045496</funding_grant_id><funding_grant_id>DK 45496</funding_grant_id><funding_grant_id>R01 DK080817</funding_grant_id><funding_grant_id>CA 151325</funding_grant_id><funding_grant_id>R01 CA149095</funding_grant_id><funding_grant_id>R01 CA151325</funding_grant_id><funding_grant_id>CA 98454</funding_grant_id><funding_grant_id>DK 080817</funding_grant_id><funding_grant_id>R01 CA051085</funding_grant_id><funding_grant_id>CA 51085</funding_grant_id><pubmed_authors>Huso DL</pubmed_authors><pubmed_authors>Murray-Stewart TR</pubmed_authors><pubmed_authors>Woster PM</pubmed_authors><pubmed_authors>Sears CL</pubmed_authors><pubmed_authors>Goodwin AC</pubmed_authors><pubmed_authors>Destefano Shields CE</pubmed_authors><pubmed_authors>Wu S</pubmed_authors><pubmed_authors>Casero RA</pubmed_authors><pubmed_authors>Hacker-Prietz A</pubmed_authors><pubmed_authors>Rabizadeh S</pubmed_authors><pubmed_authors>Wu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis.</name><description>It is estimated that the etiology of 20-30% of epithelial cancers is directly associated with inflammation, although the direct molecular events linking inflammation and carcinogenesis are poorly defined. In the context of gastrointestinal disease, the bacterium enterotoxigenic Bacteroides fragilis (ETBF) is a significant source of chronic inflammation and has been implicated as a risk factor for colorectal cancer. Spermine oxidase (SMO) is a polyamine catabolic enzyme that is highly inducible by inflammatory stimuli resulting in increased reactive oxygen species (ROS) and DNA damage. We now demonstrate that purified B. fragilis toxin (BFT) up-regulates SMO in HT29/c1 and T84 colonic epithelial cells, resulting in SMO-dependent generation of ROS and induction of ?-H2A.x, a marker of DNA damage. Further, ETBF-induced colitis in C57BL/6 mice is associated with increased SMO expression and treatment of mice with an inhibitor of polyamine catabolism, N(1),N(4)-bis(2,3-butandienyl)-1,4-butanediamine (MDL 72527), significantly reduces ETBF-induced chronic inflammation and proliferation. Most importantly, in the multiple intestinal neoplasia (Min) mouse model, treatment with MDL 72527 reduces ETBF-induced colon tumorigenesis by 69% (P &lt; 0.001). The results of these studies indicate that SMO is a source of bacteria-induced ROS directly associated with tumorigenesis and could serve as a unique target for chemoprevention.</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Sep</publication><modification>2021-03-03T08:42:11Z</modification><creation>2019-03-27T00:44:01Z</creation></dates><accession>S-EPMC3174648</accession><cross_references><pubmed>21876161</pubmed><doi>10.1073/pnas.1010203108</doi></cross_references></HashMap>